| |
| |
|
| Insider
Information: |
Tasse Daniel |
| Relationship: |
|
| City: |
Hampton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
206,194 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$167,720 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
206,194 |
|
|
| Total
Value |
$167,720 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -19.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bellerophon Therapeutics Inc |
BLPH |
Director |
2018-06-21 |
182,604 |
|
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2023-06-02 |
6,496 |
2022-06-03 |
0 |
Premium* |
|
|
DBV Technologies SA |
DBVT |
|
2024-03-08 |
17,094 |
2024-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DBVT |
DBV Technologies SA |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-08 |
4 |
B |
$0.83 |
$14,188 |
D/D |
17,094 |
17,094 |
0.01 |
% |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2023-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,486 |
6,496 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2022-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,010 |
3,010 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2018-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,987 |
182,604 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2017-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
25,363 |
170,617 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2016-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
16,356 |
145,254 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2015-02-19 |
4 |
B |
$12.00 |
$300,000 |
D/D |
25,000 |
128,898 |
2.39 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2015-02-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,562 |
|
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2015-02-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
93,336 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
